# A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)

> **NCT06701513** · — · RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 350 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Deucravacitinib

## Key facts

- **NCT ID:** NCT06701513
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-29
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06701513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06701513, "A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)". Retrieved via AI Analytics 2026-08-09 from https://api.ai-analytics.org/clinical/NCT06701513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*